Peptide Initiative
Back to Abarelix

Clinical trials

Every registered trial of Abarelix

4 studies, 1 still enrolling.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Very little human research on Abarelix has been registered.
  • 4 registered studies in total.
  • 1 is still enrolling people, so this is active research, not just history.

What kind of research

  • 4 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 2,299 people took part in those.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 4 of 4 trials for Abarelix.

  • NCT06157528 Not Yet Recruiting100 enrolled2023

    Diagnosis of Pelvic Endometriosis in MRI

    Zhenshen Ma

    Endometriosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00103623 Phase 4Suspended2,000 enrolled2004

    The Plenaxis® Experience Study

    PRAECIS Pharmaceuticals Inc.

    Prostate Cancer

  • NCT00100243 Phase 2Completed22 enrolled2004

    Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

    PRAECIS Pharmaceuticals Inc.

    Prostate Cancer

  • NCT00841113 Phase 3Completed177 enrolled1999

    Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

    Speciality European Pharma Limited

    Prostate Cancer

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Abarelix is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.